Gathered from investors, the funds will finish enrollment from 200 to 350 patients for the study. The Freedom Lumbar Disc implant includes a patented polymer between two metal plates and is used to allow a patient’s spine to move naturally.
AxioMed will also use the funds to expand European sales of the implant and gain regulatory approval for its Freedom Cervical Disc implant.
Read the Crain’s Cleveland Business report on the AxioMed Spine funds raised.
Read other coverage on AxioMed Spine.
-AxioMed Spine Receives Innovation Award From Cleveland Clinic
